Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.
Damen M, Weegink CJ, Mauser-Bunschoten EP, Cuypers HT, Hermus MC, Sillekens P, Haan E, van den Berg HM, Bresters D, Lelie PN, Chamuleau RA, Reesink HW. Damen M, et al. Among authors: reesink hw. Scand J Gastroenterol. 2001 Jan;36(1):97-104. doi: 10.1080/00365520150218129. Scand J Gastroenterol. 2001. PMID: 11218246 Clinical Trial.
Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
Bresters D, Cuypers HT, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN. Bresters D, et al. Among authors: reesink hw. J Med Virol. 1994 Jul;43(3):262-8. doi: 10.1002/jmv.1890430313. J Med Virol. 1994. PMID: 7931188 Clinical Trial.
New developments in the antiviral treatment of hepatitis C.
de Bruijne J, Weegink CJ, Jansen PL, Reesink HW. de Bruijne J, et al. Among authors: reesink hw. Vox Sang. 2009 Jul;97(1):1-12. doi: 10.1111/j.1423-0410.2009.01187.x. Epub 2009 Apr 20. Vox Sang. 2009. PMID: 19392783 Free PMC article. Review.
New developments in antiviral therapy for chronic hepatitis B.
Takkenberg RB, Weegink CJ, Zaaijer HL, Reesink HW. Takkenberg RB, et al. Among authors: reesink hw. Vox Sang. 2010 May;98(4):481-94. doi: 10.1111/j.1423-0410.2009.01282.x. Epub 2009 Nov 25. Vox Sang. 2010. PMID: 19951307 Review.
Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.
de Niet A, Takkenberg RB, Benayed R, Riley-Gillis B, Weegink CJ, Zaaijer HL, Koot M, Jansen PL, Beld MG, Lopatin U, Reesink HW. de Niet A, et al. Among authors: reesink hw. Scand J Gastroenterol. 2012 Apr;47(4):475-81. doi: 10.3109/00365521.2011.648952. Epub 2012 Jan 23. Scand J Gastroenterol. 2012. PMID: 22263608 Clinical Trial.
New developments in hepatitis C.
Reesink HW, Bresters D, van der Poel CL, Cuypers HT, Lelie PN. Reesink HW, et al. Scand J Gastroenterol Suppl. 1992;194:82-6. doi: 10.3109/00365529209096033. Scand J Gastroenterol Suppl. 1992. PMID: 1298054
353 results